These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17687163)

  • 1. More than a name.
    Blank SV; Curtin JP
    J Clin Oncol; 2007 Aug; 25(23):3551; author reply 3557-8. PubMed ID: 17687163
    [No Abstract]   [Full Text] [Related]  

  • 2. Type of oncology specialist and treatment-related outcomes in ovarian cancer.
    Hoffman MA; Iqbal U
    J Clin Oncol; 2007 Aug; 25(23):3553; author reply 3557-8. PubMed ID: 17687165
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer and the battle of the specialists.
    McGuire WP
    J Clin Oncol; 2007 Aug; 25(23):3554-5; author reply 3557-8. PubMed ID: 17687166
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists.
    Berchuck A
    J Clin Oncol; 2007 Aug; 25(23):3552; author reply 3557-8. PubMed ID: 17687164
    [No Abstract]   [Full Text] [Related]  

  • 5. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
    Markman M
    J Clin Oncol; 2007 Aug; 25(23):3554; author reply 3557-8. PubMed ID: 17687167
    [No Abstract]   [Full Text] [Related]  

  • 6. Gynecologic oncology or medical oncology: what's in a name?
    Cannistra SA
    J Clin Oncol; 2007 Apr; 25(10):1157-9. PubMed ID: 17401003
    [No Abstract]   [Full Text] [Related]  

  • 7. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
    Silber JH; Rosenbaum PR; Polsky D; Ross RN; Even-Shoshan O; Schwartz JS; Armstrong KA; Randall TC
    J Clin Oncol; 2007 Apr; 25(10):1169-75. PubMed ID: 17401005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
    Vergote I; Amant F; Leunen K
    Gynecol Oncol; 2010 Oct; 119(1):1-2. PubMed ID: 20833283
    [No Abstract]   [Full Text] [Related]  

  • 9. Gynecologic oncology.
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):131-62. PubMed ID: 8425030
    [No Abstract]   [Full Text] [Related]  

  • 10. Gynecologic oncology 2005: What it "oughta" be! Presented to Society of Gynecologic Oncologists, Miami Beach, Florida, USA, by James W. Orr, Jr., M.D.
    Orr JW
    Gynecol Oncol; 2005 Sep; 98(3):344-52. PubMed ID: 16081148
    [No Abstract]   [Full Text] [Related]  

  • 11. Key clinical trials in gynaecological oncology.
    Morrison J; Kehoe S
    Eur J Surg Oncol; 2006 Oct; 32(8):887-91. PubMed ID: 16677796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical education for gynecologic oncologists.
    Goff BA
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S45-6. PubMed ID: 19573706
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical training in gynecologic oncology affects outcome.
    Raju KS; Wolfe CD
    Gynecol Oncol; 1993 Nov; 51(2):289-91; author reply 291-2. PubMed ID: 8276311
    [No Abstract]   [Full Text] [Related]  

  • 14. The reassessment of ovarian cancer in complete clinical remission: what are our goals?
    Clarke-Pearson DL
    Gynecol Oncol; 1994 Feb; 52(2):151-3. PubMed ID: 8314131
    [No Abstract]   [Full Text] [Related]  

  • 15. The Society of Gynecologic Oncologists: yesterday, today and tomorrow.
    Copeland LJ
    Gynecol Oncol; 2007 Nov; 107(2):169-72. PubMed ID: 17950383
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for newly diagnosed ovarian cancer: It's all about selection.
    Dizon DS
    Gynecol Oncol; 2017 Feb; 144(2):241-242. PubMed ID: 28062117
    [No Abstract]   [Full Text] [Related]  

  • 18. Complementary and alternative therapy use in gynecologic oncology: implications for clinical practice.
    Richardson MA
    Gynecol Oncol; 2002 Mar; 84(3):360-2. PubMed ID: 11855869
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical education and training program development for gynecologic oncology: American perspective.
    Hoffman MS; Bodurka DC
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S47-51. PubMed ID: 19573707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of gynecologic oncology: are we headed for super-specialization?
    Gershenson DM
    Gynecol Oncol; 2011 Jul; 122(1):3-4. PubMed ID: 21536319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.